FIELD: organic chemistry, pharmacy. SUBSTANCE: invention relates to the novel isoxazolines and isoxazoles of the formula (I) where R1,R14,R15, U, V, W, X, Y and b have values given in the invention claim. Compounds are useful as antagonists of glycoprotein fibrinogen receptors IIb/IIIa of platelets. Invention relates to also pharmaceutical compositions containing these compounds, method of inhibition of platelet aggregation based on these compounds as thrombolytic agents. EFFECT: improved method of inhibition. 24 cl, 16 tbl, 2423 ex
Title | Year | Author | Number |
---|---|---|---|
CYCLIC UREAS, METHOD OF INHIBITION OF RETROVIRUS GROWTH AND PHARMACEUTICAL COMPOSITION | 1992 |
|
RU2131420C1 |
ANTHRAPYRAZOLONE DERIVATIVES, METHODS OF THEIR SYNTHESIS AND METHODS OF SYNTHESIS OF ANTHRAPYRAZOLONES FROM THEIR SHOWING ANTITUMOR ACTIVITY | 1994 |
|
RU2142456C1 |
METHOD OF SYNTHESIS OF IMIDAZOLES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALT | 1989 |
|
RU2028293C1 |
POLYCYCLIC COMPOUNDS, THEIR DERIVATIVES, PHARMACEUTICAL PREPARATIONS AS ENHANCERS AND METHOD OF TREATMENT OF INTELLECTUAL ACTIVITY DISORDER | 1994 |
|
RU2152944C1 |
1-N-ALKYL-N-ARYLPYRIMODINEAMINES, METHOD OF PATIENT TREATMENT, PHARMACEUTICAL COMPOSITION | 1994 |
|
RU2153494C2 |
CARBOCYCLIC AND HETEROCYCLIC CONDENSED COMPOUNDS OF QUINOLINE CARBOXYLIC ACID SUITED AS IMMUNODEPRESSANTS | 1994 |
|
RU2133740C1 |
CYCLIC PEPTIDES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, PHARMACEUTICAL COMPOSITION | 1992 |
|
RU2096415C1 |
ANALOGS OF Δ12,13-ISOTAXOL, INTERMEDIATE COMPOUNDS, METHOD OF SYNTHESIS OF INTERMEDIATE COMPOUNDS AND PHARMACEUTICAL COMPOSITION | 1995 |
|
RU2142950C1 |
NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVES OF FLUORENE | 1992 |
|
RU2051151C1 |
CYCLIC PEPTIDES, RADIOPHARMACEUTICAL PREPARATION, AND RADIOACTIVELY LABELED CYCLIC PEPTIDES | 1994 |
|
RU2145608C1 |
Authors
Dates
2000-05-27—Published
1994-11-14—Filed